Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart
Chin‐Yu Lin(National Yang Ming Chiao Tung University), Shih-Ann Chen(Taipei Veterans General Hospital), Tze‐Fan Chao(National Yang Ming Chiao Tung University), Eric Chong(Alexandra Hospital), Yun‐Yu Chen(National Chung Hsing University), Jo‐Nan Liao(L-3 Communications (United States)), Ta‐Chuan Tuan(National Yang Ming Chiao Tung University), Yu‐Feng Hu(Albert Einstein College of Medicine), Yenn‐Jiang Lin(National Yang Ming Chiao Tung University), Yao‐Ting Chang(National Yang Ming Chiao Tung University), Kuo‐Liong Chien(University of Liverpool), Li‐Wei Lo(National Yang Ming Chiao Tung University), Fa‐Po Chung(L-3 Communications (United States)), Chuen‐Wang Chiou(National Yang Ming Chiao Tung University), Shih‐Lin Chang(National Yang Ming Chiao Tung University)
Cited by 18
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Screening for Atrial Fibrillation
|Circulation|2017|535
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
|Thrombosis and Haemostasis|2021|476
Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality
|Circulation|2019|335
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
|Journal of the American College of Cardiology|2015|258